Insider activity is hot in names like Vestis (NYSE: VSTS), OPKO Health (NASDAQ: OPK), and Greif, Inc. (NYSE: GEF), and investors should take notice. From board members to CEOs, CFOs, and other corporate officers, insiders are buying these stocks en masse, signaling a higher-than-average conviction in the share price outlook.
The question for investors is if these stocks are a good buy for 2025 and how high their share prices may go. In two cases the answer is quite high because the support of analysts, institutions, and retail investors is strong. In the other, investors may want to avoid the stock because the risk of dilution is great. Here’s why.
